Paradigm Biocapital Advisors LP EWTX Holdings History
Paradigm Biocapital Advisors LP's Edgewise Therapeutics Inc Holding Summary
As of 2025-03-31, Paradigm Biocapital Advisors LP held 4.39 Mil shares of Edgewise Therapeutics Inc(EWTX), totaling $96.68 Mil. This investment constitutes 4.43% of their stock portfolio, and Paradigm Biocapital Advisors LP now holds 4.18% of the outstanding Edgewise Therapeutics Inc(EWTX) stock.
The initial trade took place in 2024Q1. And since then Paradigm Biocapital Advisors LP has made 3 purchases of EWTX, at an average price of $22.21, for a total of 4.61 Mil shares. In addition, there have been 2 sales at an average price of $21.41 for 220,297.00 shares. Based on historical transaction data and EWTX's current price of $13.45, Paradigm Biocapital Advisors LP's estimated gain on his EWTX holdings is $-38.67 Mil, reflecting a -37.73% gain to date.
Paradigm Biocapital Advisors LP EWTX ($13.45) Holding Chart
Paradigm Biocapital Advisors LP EWTX ($13.45) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1